Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review

Sangeeta Dhami; Ulugbek Nurmatov; Giovanni Battista Pajno; Montserrat Fernandez-Rivas; Antonella Muraro; Graham Roberts; Cezmi Akdis; Montserrat Alvaro-Lozano; Kirsten Beyer; Carsten Bindslev-Jensen; Wesley Burks; George du Toit; Motohiro Ebisawa; Philippe Eigenmann; Edward Knol; Mika Makela; Kari Christine Nadeau; Liam O'Mahony; Nikolaos Papadopoulos; Lars Poulsen; Cansin Sackesen; Hugh Sampson; Alexandra Santos; Ronald van Ree; Frans Timmermans; Aziz Sheikh

doi:10.1186/s13601-016-0113-z

Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review

Sangeeta Dhami, Ulugbek Nurmatov, Giovanni Battista Pajno, Montserrat Fernandez-Rivas, Antonella Muraro, Graham Roberts, Cezmi Akdis, Montserrat Alvaro-Lozano, Kirsten Beyer, Carsten Bindslev-Jensen, Wesley Burks, George du Toit, Motohiro Ebisawa, Philippe Eigenmann, Edward Knol, Mika Makela, Kari Christine Nadeau, Liam O'Mahony, Nikolaos Papadopoulos, Lars PoulsenCansin Sackesen, Hugh Sampson, Alexandra Santos, Ronald van Ree, Frans Timmermans, Aziz Sheikh

Research output: Contribution to journal › Article › Academic › peer-review

1 Downloads (Pure)

Abstract

BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy.

METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.

DISCUSSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.

Original language	English
Article number	6:24
Journal	Clinical and Translational Allergy
Volume	6
DOIs	https://doi.org/10.1186/s13601-016-0113-z
Publication status	Published - 2016

Keywords

Allergy
Allergen immunotherapy
Food allergy
Therapy
Sensitisation

Access to Document

10.1186/s13601-016-0113-z

13-zFinal published version, 948 KB

Cite this

Dhami, S., Nurmatov, U., Pajno, G. B., Fernandez-Rivas, M., Muraro, A., Roberts, G., Akdis, C., Alvaro-Lozano, M., Beyer, K., Bindslev-Jensen, C., Burks, W., du Toit, G., Ebisawa, M., Eigenmann, P., Knol, E., Makela, M., Nadeau, K. C., O'Mahony, L., Papadopoulos, N., ... Sheikh, A. (2016). Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review. Clinical and Translational Allergy, 6, Article 6:24. https://doi.org/10.1186/s13601-016-0113-z

@article{0735bd158e63431c98f2a884ab59b8ad,

title = "Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review",

abstract = "BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy.METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.DISCUSSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.",

keywords = "Allergy, Allergen immunotherapy, Food allergy, Therapy, Sensitisation",

author = "Sangeeta Dhami and Ulugbek Nurmatov and Pajno, {Giovanni Battista} and Montserrat Fernandez-Rivas and Antonella Muraro and Graham Roberts and Cezmi Akdis and Montserrat Alvaro-Lozano and Kirsten Beyer and Carsten Bindslev-Jensen and Wesley Burks and {du Toit}, George and Motohiro Ebisawa and Philippe Eigenmann and Edward Knol and Mika Makela and Nadeau, {Kari Christine} and Liam O'Mahony and Nikolaos Papadopoulos and Lars Poulsen and Cansin Sackesen and Hugh Sampson and Alexandra Santos and {van Ree}, Ronald and Frans Timmermans and Aziz Sheikh",

year = "2016",

doi = "10.1186/s13601-016-0113-z",

language = "English",

volume = "6",

journal = "Clinical and Translational Allergy",

issn = "2045-7022",

publisher = "BioMed Central",

}

Dhami, S, Nurmatov, U, Pajno, GB, Fernandez-Rivas, M, Muraro, A, Roberts, G, Akdis, C, Alvaro-Lozano, M, Beyer, K, Bindslev-Jensen, C, Burks, W, du Toit, G, Ebisawa, M, Eigenmann, P, Knol, E, Makela, M, Nadeau, KC, O'Mahony, L, Papadopoulos, N, Poulsen, L, Sackesen, C, Sampson, H, Santos, A, van Ree, R, Timmermans, F & Sheikh, A 2016, 'Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review', Clinical and Translational Allergy, vol. 6, 6:24. https://doi.org/10.1186/s13601-016-0113-z

TY - JOUR

T1 - Allergen immunotherapy for IgE-mediated food allergy

T2 - protocol for a systematic review

AU - Dhami, Sangeeta

AU - Nurmatov, Ulugbek

AU - Pajno, Giovanni Battista

AU - Fernandez-Rivas, Montserrat

AU - Muraro, Antonella

AU - Roberts, Graham

AU - Akdis, Cezmi

AU - Alvaro-Lozano, Montserrat

AU - Beyer, Kirsten

AU - Bindslev-Jensen, Carsten

AU - Burks, Wesley

AU - du Toit, George

AU - Ebisawa, Motohiro

AU - Eigenmann, Philippe

AU - Knol, Edward

AU - Makela, Mika

AU - Nadeau, Kari Christine

AU - O'Mahony, Liam

AU - Papadopoulos, Nikolaos

AU - Poulsen, Lars

AU - Sackesen, Cansin

AU - Sampson, Hugh

AU - Santos, Alexandra

AU - van Ree, Ronald

AU - Timmermans, Frans

AU - Sheikh, Aziz

PY - 2016

Y1 - 2016

N2 - BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy.METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.DISCUSSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.

AB - BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for IgE-mediated food allergy. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in IgE-mediated food allergy.METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.DISCUSSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.

KW - Allergy

KW - Allergen immunotherapy

KW - Food allergy

KW - Therapy

KW - Sensitisation

U2 - 10.1186/s13601-016-0113-z

DO - 10.1186/s13601-016-0113-z

M3 - Article

C2 - 27382460

SN - 2045-7022

VL - 6

JO - Clinical and Translational Allergy

JF - Clinical and Translational Allergy

M1 - 6:24

ER -

Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review

Abstract

Keywords

Access to Document

Fingerprint

Cite this